by Jennifer E. Miller
The public’s “negative view of the pharmaceutical industry is a major problem… (and there is) no shortage of “experts” with solutions on how to fix the problem. Unfortunately, many of the proposals are shockingly naïve and without merit,” grumbles John LaMattina, former President of Pfizer Global R&D. In response to LaMattina’s challenge for outsiders to develop more realistic reform strategies, this blog post proposes the introduction of an ethics accreditation system, akin to a Good Housekeeping Seal, as a practical means for the industry to credibly improve its ethics and restore its broken image.
... Read more about A Good Housekeeping Seal for Bioethics: Could It Improve Trust and Ethics in the Pharmaceutical Industry?
